Shares of UnitedHealth Group closed down 7.3% to $465.69 on Friday. Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Additionally, the department blocked UnitedHealth’s $3.3 billion acquisition of Amedisys, a home health company last year. UnitedHealth Group is the parent company of UnitedHealthcare ...

In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year end results.

Also, UnitedHealth has clarified that the company ... although the DoJ has sued to block the deal with Amedisys, although a trial isn’t expected to take place until later this year or even ...

Try Now>> See the top stocks recommended by analysts >> Read More on AMED: Amedisys NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health ...